Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,423
+$5,389 QoQ
Shares Held
742
+195.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. LYEL ranks #280 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,423 | 742 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,034 | 251 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $738 | 24 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,996 | 4,187 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $220 | 25 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $10,623 | 19,746 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $15,064 | 23,539 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,053 | 16,706 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,916 | 15,115 | Shares | Sole | 2024-11-06 | |
| 2024-03-31 | $8,955 | 4,016 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $99,113 | 51,090 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,900 | 29,184 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,570 | 18,104 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,844 | 9,680 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $74,670 | 21,519 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,444 | 2,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,350 | 974 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $46,025 | 9,114 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,046 | 5,174 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $41,632 | 2,813 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||